Cefamandole Nafate
Generic Name: cefamandole nafate
Manufactured by LILLY. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CEFAMANDOLE NAFATE (EQ 2GM BASE/VIAL). Application: NDA050504.
Overview
Manufactured by LILLY. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CEFAMANDOLE NAFATE (EQ 2GM BASE/VIAL). Application: NDA050504.
Dosage
Available as injectable for injection use.
Related Medications
Dextromethorphann Hbr, Guaifenesin
dextromethorphann hbr, guaifenesin
Expectorant [EPC]
Purpose Cough suppressant Expectorant
Memantine And Donepezil
memantine and donepezil
11 DESCRIPTION Memantine and donepezil hydrochlorides extended-release capsules contain memantine, an orally active NMDA receptor antagonist, as the hydrochloride salt and donepezil, a reversible inhibitor of the enzyme acetylcholinesterase, as the hydrochloride salt.
Ticagrelor
ticagrelor
P2Y12 Platelet Inhibitor [EPC]
11 DESCRIPTION Ticagrelor tablets contains ticagrelor, a cyclopentyltriazolopyrimidine, inhibitor of platelet activation and aggregation mediated by the P2Y12 ADP-receptor. Chemically it is (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5- d ]-pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol The molecular formula of ticagrelor is C 23 H 28 F 2 N 6 O 4 S and its molecular weight is 522.6.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.